BMO Capital Markets (:) has been given an average recommendation of “N/A” by the zero ratings firms that are presently covering the stock, MarketBeat.com reports.

WARNING: “BMO Capital Markets () Given Consensus Rating of “” by Analysts” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another domain, it was illegally stolen and republished in violation of United States & international copyright and trademark legislation. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/19/analysts-anticipate-aldeyra-therapeutics-inc-aldx-will-announce-earnings-of-0-41-per-share-updated-updated-updated.html.

About BMO Capital Markets

BMO Capital Markets is the investment banking and capital markets arm of Bank of Montreal, aka BMO Financial Group. It serves corporate, institutional, and government clients in North America, providing equity and debt underwriting, corporate lending and project finance, M&A advisory, and equity and debt research.

Receive News & Stock Ratings for BMO Capital Markets Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BMO Capital Markets and related stocks with our FREE daily email newsletter.